The Leukemia Lymphoma Society S Therapy Acceleration Program vs Fady Abdel Nour compared for founders deciding who to pitch.
The Leukemia Lymphoma Society S Therapy Acceleration Program is a venture capital based in New York, New York, United States. Fady Abdel Nour is a accelerator based in New York across 1,800 portfolio companies. Sector focus diverges: The Leukemia Lymphoma Society S Therapy Acceleration Program concentrates on generalist deals and Fady Abdel Nour on Artificial Intelligence. On stage, The Leukemia Lymphoma Society S Therapy Acceleration Program is active at undisclosed stages and Fady Abdel Nour at Pre Seed.
Investors like The Leukemia Lymphoma Society S Therapy Acceleration Program · Investors like Fady Abdel Nour · The Leukemia Lymphoma Society S Therapy Acceleration Program co-investors · Full investor directory